chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st dose fever constant 24hr/day headache joint and muscle pain for 3 weeks. Treated at home with naproxen BID. Did telehealth appointment through insurance company on 21st (2 weeks in) to see if I needed to be concerned they sent me for covid test said if negative it was just still vaccine reaction and to let it run its course. Covid results were negative. Fever included feeling like I had a fever with hot flashes waking up covered in sweat and cold chills where I was so cold nothing helped me warm up. Then it all went away as suddenly as it came on and I had less than a week before the 2nd dose. Saw my rheumatologist during this time he said it was probably my MCAS causing the reaction but ok me getting the second shot. Second dose almost exactly at 24 hour mark started feeling round down and sickly took temp at hour 25 and had fever again. We are at 2.5 weeks post 2nd dose. So far I had fever and much milder joint and muscle pain this time but no headache. Again treated at home with naproxen BID. Sometimes tramadol for joint pain too. I havent felt feverish for over 24 hours now so I think it's gone this time which makes this event 2.5 weeks.
Arm became very hot; Arm became very hard; Arm became very red/ redness covered a 3 inch X 4 inch area of upper arm; Smaller patch of purplish/red showed near the injection area; Smaller patch of purplish/red showed near the injection area; Injection site discomfort; This case was reported by a consumer and described the occurrence of skin warm in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced skin warm, induration, erythema of extremities, red rash, rash and arm discomfort. On an unknown date, the outcome of the skin warm, induration, erythema of extremities, red rash, rash and arm discomfort were recovered/resolved.   It was unknown if the reporter considered the skin warm, induration, erythema of extremities, red rash, rash and arm discomfort to be related to Shingrix.  Additional case details were provided as follows: The patient asked some questions about the side effects developed after vaccination. The age at vaccination was not reported. The patient's arm became very hot, hard and red after the vaccination. The redness covered a 3 inch by 4 inch area of upper arm.  These events lasted for 5 days, then it cleared and the patient felt fine.  The patient stated, nearly a week after clearing these events, a smaller patch of purplish or red colour showed near the injection area along with renewed discomfort.  This had lasted 5 days so far. The patient had consulted pharmacist and doctor. They said to contact back if it got worst or did not get better.  The patient felt fine otherwise and asked if this just an abnormal reaction to the vaccine.
tested positive for coronavirus; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2, dose 1 via an unspecified route of administration on 15Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was scheduled for the second dose on 06May2021 (exactly 21 days apart). However, he was tested positive for coronavirus on 20Apr2021. He was asking if he should still take the second dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 20Apr2021. The outcome of event is unknown. No treatment information was provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Nausea, Fever, Body cramps lasted for 36 hours and then fever continued for 48 hours. No treatment other than bedrest, Tylenol.
Patient comes to pharmacy this morning, and states that he is not feel well after the shingles vaccines 3 days ago.  Recommend patient to see doctor or see medical attention, but patient denies and wants to look for over-the-counter med, that already recommend him Tylenol. Now, this afternoon to  follow up with patient, patient is no longer shivering, but patient's  fever is come and go, low rate fever, patient is tired, and still taking Tylenol, feel pain in the chest when he cough due to he is out of breath. Suggest patient go to hospital immediately.
Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by an HCP and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported.  It was unknown if the patient was tested positive or diagnosed with COVID-19. It was unknown if acute illnesses at the time of vaccination and up to one month before. And it was unknown if chronic or long-standing health conditions.  The vaccine was used beyond use date of some lot numbers for Moderna that were administered to patients. There was no adverse reaction noted or reported to the reporter ever regarding after administration of vaccine.  No treatment drug details was reported.
Pt experienced dizziness / vertigo and developed a mild fever the evening after receiving the vaccine.
Current symptoms are ear ringing and tingling all over.; 5 minutes after injection I had ear ringing that has persisted. Additionally, I was woken with  extreme nausea after ~56 hours and was ill for 24 hours. Current symptoms are ear ringing and tingling a; 5 minutes after injection I had ear ringing that has persisted. Additionally, I was woken with  extreme nausea after ~56 hours and was ill for 24 hours. Current symptoms are ear ringing and tingling a; This is a spontaneous report from a contactable other healthcare professional. A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: unknown ), via an unspecified route of administration (left arm) on 29Dec2020 15:30 at SINGLE DOSE for COVID-19 immunization. Medical history included migraine and allergies to penicillin from an unknown date. No other vaccine was taken in four weeks. The patient was not diagnosed with COVID-19 prior vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included rizatriptan benzoate (MAXALT) from an unspecified date. On 29Dec2020 15:35, 5 minutes after injection, the patient had ear ringing that has persisted. Additionally, she was woken with extreme nausea after 56 hours, on 31Dec2020 23:30 (also reported as 29Dec2020 03:45), and was ill for 24 hours. Current symptoms were ear ringing and tingling all over. Treatment was not given. Event outcome was not recovered. The reporter considered the events as non-serious.  Information on the lot/batch number has been requested.
I began to get weird blisters the day after the second shot. Then after that, a rash started to develop on my torso, and has now grown to over 65 percent of my body.
UTI; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program. This is one of 3 reports.  A female patient received BNT162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: URINARY TRACT INFECTION (non-serious), outcome "unknown", described as "UTI".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021391051 Same reporter/suspect product/event, different patient.
A nurse reported that a 10 month old male received an injection of Prevnar on 5/2/00. One day post vax, the pt developed a fever of 103.6 and a red, warm, raised nodule at the injection site. He was seen by the physician. White blood cell count was 22700 cells. The physician prescribed ceftrixone and amoxicillin and clavulanate. As of 5/5/00, the fever was lower and the injection site nodule was beginning to resolve.
Client with appointment for Moderna Bivalent Booster received 0.25 at 1145am and returned to clinic 2pm for second 0.25 dosage of Moderna Bivalent Booster. Client tolerated well
A nurse reported the occurrence of possible anxiety or hypersensitivity in a 26 year old male who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis.  The subject had no relevant medical history, concurrent conditions, concurrent medications, or concurrent vaccines.  On 03/13/03, the subject received his first injection of Engerix-B (Lot # ENG5338A6).  He was "very anxious about receiving Engerix-B".  After the injection, he experienced nausea, dizziness, and a headache.  The subject's blood pressure and pulse were "fine".  The nurse reported that a diagnosis of "question of hypersensitivity versus anxiety" was made.  The events resolved on 03/13/03.  The reporting nurse considered the events to be possibly related to Engerix-B administration.  The subject received his second injection of Engerix-B on 04/15/03.  No adverse events occurred.
she won't be getting the second dose of the vaccine; chills; headaches; side effects that she is not comfortable with; "Everything it's sticking to me and I don't like it at all"  to her arm and forehead.; she laid down on her phone and it got stuck to her arm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (side effects that she is not comfortable with), VACCINATION COMPLICATION ("Everything it's sticking to me and I don't like it at all"  to her arm and forehead.), LIMB DISCOMFORT (she laid down on her phone and it got stuck to her arm), INTENTIONAL DOSE OMISSION (she won't be getting the second dose of the vaccine) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced DISCOMFORT (side effects that she is not comfortable with), VACCINATION COMPLICATION ("Everything it's sticking to me and I don't like it at all"  to her arm and forehead.), LIMB DISCOMFORT (she laid down on her phone and it got stuck to her arm), CHILLS (chills) and HEADACHE (headaches). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (she won't be getting the second dose of the vaccine). At the time of the report, DISCOMFORT (side effects that she is not comfortable with), VACCINATION COMPLICATION ("Everything it's sticking to me and I don't like it at all"  to her arm and forehead.), LIMB DISCOMFORT (she laid down on her phone and it got stuck to her arm), INTENTIONAL DOSE OMISSION (she won't be getting the second dose of the vaccine), CHILLS (chills) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not reported.
Pt received Fluzone injection on 12/18/202.  Pt reported limited ROM at Left Arm and took OTC and Ibuprofen, reported to after hours Triage.  On 12/21/2020, pt talked to Triage Nurse and reported increased sharp pain when trying to move her arm on Saturday and that she used heat/ice and ibuprofen.  Pt reported on 12/21/2020 that sharp pain continues when she tries to lift her arm and that it was dull when she is not using her arm.  She stated that over the weekend that she was awakened by sharp pain at her arm but denied redness or swelling at injection site.  Pt stated that injection was done high on the shoulder and patient stated that she believes shot was given to high and sent in picture of where bandaid was placed.  Dr. consulted on 12/21/2020 and 5 days worth of prednisone 20 mg  sent in for patient on 12/21/2020 and told to follow up with office if issues continue.  Pt messaged in on 12/30/2020 and stated that she only took one of the five prednisone, stating she was afraid that it would keep her up all night.  Pt then advised to take 2 - 20 mg prednisone per day and Dr. advised patient to follow up with any more issues.  Pt messaged in on 1/5/2021 stating that she is 60% better but continuing to have pain and discomfort with movement.  Dr. continues to monitor and Dr. made referral to ortho specialist.
STARTED HAVING CHEST PAIN AT 10:00 PM ON 07.27.2022. CHEST PAIN GOT WORSE AND HEART STARTING RACING AT 11:00PM. WENT TO ER AT HOSPITAL, WAS TRANSPORTED TO DIFFERENT HOSPITAL.  WAS ADMITTED TO THE CARDIAC FLOOR. DX WITH AFIB. HOSPITALIZED X 1 DAY.
16 min after injection i feltmlike i needed fresh air as it felt like i couldn't get a good breath. I asked to go outside and was told no. I moved from back to the front as i felt cold and was swearing. It was sift chsnge and the staff was huddled in a corner and i called for help.2x before taking off my mask amd callinf a thried time. By this point i felt like vomiting and nedded immediate water. The thirst was intrnse. The University of Arizona didn't have anything for me to throw-up into except a half full used large janitorial garbage can.  I was given water and that really helped the thirst and nausea. The nurse came and put a monitor on my finger and immediately took me to a back area where rhe cold sweat and chills now covered my whole body and the thirst returned. Tje nurse took my vitals and i remember my heartbeat reading in the 30s and had a very low blood pressure. No one ever experienced what was happening and i asked if i was going to die. The only thing they had to lie down on was an army cot 6" off rhe ground. I wanted to lie down so badly buy it had no sheets, pillow or anything. With all the money they get from the feds they should be able to afford a gurney. I was never told the truth about what had happened to me. I was let go with a very low heart rate of 51. My normal is 68 to 78. No follow up instructions.
tiredness; headache; fever; nausea; chills; Pain at injection site; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 15Dec2021 13:30 (Lot number: FH8027) at the age of 53 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: PANTOPRAZOLE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Left), administration date: 25Mar2021, when the patient was 52 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left), administration date: 03Mar2021, when the patient was 52 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 15Dec2021 13:30, outcome "not recovered", described as "Booster"; FATIGUE (non-serious) with onset 16Dec2021, outcome "recovered" (20Dec2021), described as "tiredness"; HEADACHE (non-serious) with onset 16Dec2021, outcome "recovered" (20Dec2021), described as "headache"; PYREXIA (non-serious) with onset 16Dec2021, outcome "recovered" (20Dec2021), described as "fever"; NAUSEA (non-serious) with onset 16Dec2021, outcome "recovered" (20Dec2021), described as "nausea"; CHILLS (non-serious) with onset 16Dec2021, outcome "recovered" (20Dec2021), described as "chills"; VACCINATION SITE PAIN (non-serious) with onset 15Dec2021 18:00, outcome "recovered" (20Dec2021), described as "Pain at injection site". Therapeutic measures were not taken as a result of immunisation, fatigue, headache, pyrexia, nausea, chills, vaccination site pain.  Additional information: Patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient not tested for COVID-19. No known allergies.  No follow-up attempts are possible. No further information is expected.
pt recv vax 4SEP96 1130AM;Wednesday noc pt had moderate fever & was awoke & restless;Thursday-no appetite, lethargic, bump @ site;mom giving APAP;Friday no fever, no itching, appetite & energy level nl; had rash - bump 1 1/2" by 2";
Swollen bump on lower neck on the right side (side of vaccination site). Bump was extremely tender at first, bump has not gone down after 4 days and neck is extremely stiff and sore but more tolerable to touch.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concurrent conditions, medical history, or concomitant medications.  On or about 01-MAR-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, reported as subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was not provided.  The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
1025 Pt. complains of intense itchiness on upper body. Dizzy when standing. No shortness of breath. Mouth, tongue and throat all feel normal.  1028 Pt. given 50mg Benadryl per Dr. order.  1032 BP 120/80, HR 73.  1101 Pt. feeling better and released per physician
Moderna COVID-19 vaccine EUA: fever 99.5, slight nausea, headache; took Tylenol/every 8 hours and felt better
Pain, swelling and large area of erythema redness. Patient called on call doctor after hours with complaint.
Lump at site , rash on left  shoulder, face , neck , trunk , dizziness, headache , ear red
The patient received the Janssen vaccine lot #1808980 exp 06/20/2021 at0930am in the left arm.  Patient has a history of asthma, high blood pressure, anxiety, and hearing voices.  He takes lisinopril and zyprexa. He was in the hospital recently due to hearing voices but can not remember how long ago.  He is living at a recuperative care shelter.  Patient denied drug use, denies prior vaccine reactions, and said he was allergic to Geodon which makes him brake out in a rash.  The patient was  sitting in the observation area after receiving his vaccine.  At 09:35am he said he had 8/10 "sharp chest pain" that started after receiving the vaccine.  He was warm to touch, non diaphoretics, no dizziness or nausea, and color was appropriate for race.  He was AOx4.  BP 139/90, RR 18, HR 91 and regular per palpation, Spo2 95% and no respiratory distress noted.  At 0935 the patient said the pain "went away" and said it was now a 0 out of 10.  He said he has had that sharp pain the past and has seen a doctor but he doesn't know what causes it. Vitals were rechecked.  BP 130/92, RR 18, SpO2 95%, HR94.  Patient remained alert and oriented.  Patient remained with RN in observation area until 10am and continued to deny pain or any other symptoms.  At 10am patient stood up.  He denied dizziness or pain and walked away with a steady gait. The patient was educated to see his primary care physician about the periodic chest pain.  Patient says he smokes 1 pack of cigarettes per day.
Patient noticed redness and itchiness on the arm where he received the vaccination starting two days after the vaccination. He used a steroid cream he had at home and the itchiness decreased. He thought the area of redness increased slightly on the third day after the vaccination. He had not sought treatment at the time of reporting.
On 3/6/21, pt received second dose of Moderna Covid Vaccine. He developed a diffuse skin rash and fatigue, he presented to the ED with progressive shortness of breath. He was diagnosed with cold-agglutinin hemolytic anemia. He was treated with steroids and was discharged from the hospital with a Hgb of 11.9.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information reported regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On an unspecified date, the patient received a dose of ZOSTAVAX 19400 Plaque-Forming Unit (PFU) subcutaneously (dose number and anatomical location were not reported), lot number N025703 and expiration date 16-DEC-2018, for prophylaxis, after it had expired (expired product administered). No adverse effects were reported in the patient.
Sudden onset high fever (102.6) at home.  Responded with Tylenol. Lab values showed CSF and WBC changes.
CHILLS; FEVER; MUSCLE ACHE; PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced fever. On 14-MAR-2021, the subject experienced muscle ache. On 14-MAR-2021, the subject experienced pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, muscle ache, chills, and pain at injection site. This report was non-serious.